Rapport Therapeutics Inc (RAPP)

05:17 AM

JMP reiterates Market Outperform rating on Rapport Therapeutics stock By Investing.com - Investing.com Canada

05:17 AM

Jul 15, 2025

What makes PTC Therapeutics Inc. stock price move sharplyTop Momentum Stock Pick - Newser

Jul 15, 2025

Jul 15, 2025

Why CRMD stock attracts strong analyst attentionAlpha Stock Ideas - Newser

Jul 15, 2025

Jul 15, 2025

Why Rapport Therapeutics Inc. stock attracts strong analyst attentionElite Investor Club - Newser

Jul 15, 2025

Jul 15, 2025

How High Can MOON(moon coin) GoFree Wealth-Building Investment Strategies - Newser

Jul 15, 2025

Jul 15, 2025

How Rapport Therapeutics Inc. stock performs during market volatilitySmart Money Signals - Newser

Jul 15, 2025

Jul 15, 2025

Why Entegris Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025

Jul 15, 2025

Why Coya Therapeutics Inc. stock attracts strong analyst attentionTop Analyst Picks - Newser

Jul 15, 2025

Jul 15, 2025

What makes CIGI stock price move sharplyHigh Return Intraday Picks - Newser

Jul 15, 2025

Jul 15, 2025

What makes Rapport Therapeutics Inc. stock price move sharplyFree Insider Trading Tips - Newser

Jul 15, 2025

Jul 15, 2025

How American Water Works Company Inc. stock performs during market volatilityChart Breakout Alert - Newser

Jul 15, 2025

Jul 15, 2025

When CLEU stock expected to show significant growthIs SXTC stock a good long term investment optionTriple Return With Stability - Newser

Jul 15, 2025

Jul 15, 2025

Why SPHL stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser

Jul 15, 2025

Jul 15, 2025

Leverage AI to enhance your marketing strategy with real time consumer insightsHigh Return Setup Scanner - Newser

Jul 15, 2025

Jul 14, 2025

Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest

Jul 14, 2025

Jul 11, 2025

Rapport Therapeutics’ (RAPP) Market Outperform Rating Reiterated at JMP Securities - Defense World

Jul 11, 2025

Jul 08, 2025

How will RAPP's Q1 2025 earnings forecast impact investors? - AInvest

Jul 08, 2025

Jun 30, 2025

Rapport Therapeutics, Inc.(NasdaqGM: RAPP) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Jun 20, 2025

How To Trade (RAPP) - news.stocktradersdaily.com

Jun 20, 2025

Jun 17, 2025

GAMMA Investing LLC Purchases 9,198 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 17, 2025

Jun 17, 2025

Bank of America Corp DE Sells 12,532 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 17, 2025

Jun 13, 2025

California State Teachers Retirement System Purchases 7,886 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 13, 2025

Jun 12, 2025

Analysts Can't Get Enough of These Little-Known Biopharma Stocks - Investing.com

Jun 12, 2025

Jun 12, 2025

Analysts Can't Get Enough of These Little-Known Biopharma Stocks - MarketBeat

Jun 12, 2025

Jun 09, 2025

(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 09, 2025

Jun 05, 2025

Rapport Therapeutics management to meet with Citizens JMP - TipRanks

Jun 05, 2025

Jun 05, 2025

Deutsche Bank AG Invests $41,000 in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 05, 2025

Jun 04, 2025

Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail

Jun 04, 2025

Jun 03, 2025

Stifel reiterates buy rating for Rapport Therapeutics stock By Investing.com - Investing.com Nigeria

Jun 03, 2025

Jun 03, 2025

Citizens JMP maintains positive outlook on Rapport Therapeutics stock By Investing.com - Investing.com UK

Jun 03, 2025

Jun 02, 2025

Rapport Therapeutics Completes Enrollment for Phase 2a Trial - TipRanks

Jun 02, 2025

Jun 02, 2025

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates - GlobeNewswire

Jun 02, 2025

Jun 02, 2025

Rapport Therapeutics Hosts Inaugural Investor and Analyst Day to Update on RAP-219 and Clinical Pipeline - Nasdaq

Jun 02, 2025

May 28, 2025

How the (RAPP) price action is used to our Advantage - news.stocktradersdaily.com

May 28, 2025

May 27, 2025

Rapport Therapeutics to Participate in the Jefferies Global - GlobeNewswire

May 27, 2025

May 26, 2025

Rapport Therapeutics (RAPP) to Release Quarterly Earnings on Monday - Defense World

May 26, 2025

May 21, 2025

Rapport Therapeutics to Host 2025 Investor and Analyst Day - GlobeNewswire

May 21, 2025

May 16, 2025

Companies Like Rapport Therapeutics (NASDAQ:RAPP) Are In A Position To Invest In Growth - Yahoo Finance

May 16, 2025

May 14, 2025

Rapport Therapeutics Reports Q1 2025 Financial Results - MSN

May 14, 2025

May 13, 2025

Wells Fargo & Company MN Grows Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

May 13, 2025

May 11, 2025

Barclays PLC Buys 5,634 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

May 11, 2025

May 08, 2025

Rapport Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025

May 08, 2025

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update - The Manila Times

May 08, 2025

May 07, 2025

(RAPP) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 07, 2025

May 07, 2025

Charles River agrees with Elliott to add new directors, review business - The Mighty 790 KFGO

May 07, 2025

May 06, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 06, 2025

May 02, 2025

Legal & General Group Plc Buys 8,614 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

May 02, 2025

Apr 28, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 28, 2025

Apr 22, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Apr 22, 2025